Ildong Pharmaceutical Co., Ltd. (249420.KS)
KRW 11350.0
(-5.42%)
KRW 11350.0
(-5.42%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | -2920.01 KRW | 45.89% |
| 2022 | -5396.73 KRW | -27.13% |
| 2021 | -4244.99 KRW | -675.57% |
| 2020 | -547.34 KRW | 3.14% |
| 2019 | -565.08 KRW | -205.7% |
| 2018 | 534.63 KRW | -38.98% |
| 2017 | 876.19 KRW | 43.55% |
| 2016 | 610.39 KRW | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q2 | -115.96 KRW | -288.74% |
| 2024 Q3 | -408.48 KRW | -199.99% |
| 2024 Q1 | -29.83 KRW | -158.85% |
| 2023 Q2 | -892.53 KRW | -120.93% |
| 2023 Q3 | -1710.92 KRW | -91.69% |
| 2023 Q4 | 50.69 KRW | 102.96% |
| 2023 FY | - KRW | 45.89% |
| 2023 Q1 | -403.99 KRW | 79.95% |
| 2022 Q4 | -2015.40 KRW | -219.86% |
| 2022 Q3 | -630.08 KRW | -133.43% |
| 2022 Q2 | 1885.00 KRW | 138.77% |
| 2022 Q1 | -4862.14 KRW | -23.37% |
| 2022 FY | - KRW | -27.13% |
| 2021 Q4 | -3941.03 KRW | -1900.52% |
| 2021 Q2 | 488.00 KRW | 190.04% |
| 2021 Q3 | -197.00 KRW | -140.37% |
| 2021 FY | - KRW | -675.57% |
| 2021 Q1 | -542.00 KRW | 31.88% |
| 2020 FY | - KRW | 3.14% |
| 2020 Q4 | -795.63 KRW | -2193.76% |
| 2020 Q3 | 38.00 KRW | -85.5% |
| 2020 Q1 | -52.00 KRW | 93.98% |
| 2020 Q2 | 262.00 KRW | 603.85% |
| 2019 FY | - KRW | -205.7% |
| 2019 Q2 | 251.43 KRW | 9.09% |
| 2019 Q3 | -193.33 KRW | -176.89% |
| 2019 Q4 | -863.97 KRW | -346.89% |
| 2019 Q1 | 230.48 KRW | 298.3% |
| 2018 Q4 | -116.23 KRW | -192.86% |
| 2018 Q1 | 246.71 KRW | 37.79% |
| 2018 Q2 | 247.62 KRW | 0.37% |
| 2018 FY | - KRW | -38.98% |
| 2018 Q3 | 125.17 KRW | -49.45% |
| 2017 Q3 | 317.75 KRW | 49.19% |
| 2017 Q2 | 212.99 KRW | 125.7% |
| 2017 FY | - KRW | 43.55% |
| 2017 Q4 | 179.05 KRW | -43.65% |
| 2017 Q1 | 94.37 KRW | -74.23% |
| 2016 Q4 | 366.13 KRW | 116.36% |
| 2016 FY | - KRW | 0.0% |
| 2016 Q3 | 169.22 KRW | 0.0% |